Can a diabetes pill protect a new liver from fat?
NCT ID NCT05042505
Summary
This study compared two common diabetes pills, dapagliflozin and sitagliptin, in 100 people with diabetes who had received a liver transplant. The main goal was to see which drug was better at reducing fat buildup in the new liver and improving body composition (like reducing belly fat). Researchers also monitored how well the drugs controlled blood sugar and their safety over one year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Division Of Endocrinology & Diabetes, Medanta The Medicity
Gurgaon, Haryana, 122001, India
Conditions
Explore the condition pages connected to this study.